Skip to main content
Premium Trial:

Request an Annual Quote

Agilent Awards Harvard Researcher $373K for Protein Research Using NMR

NEW YORK (GenomeWeb News) – Agilent Technologies and the Agilent Technologies Foundation announced today a three-year, nearly $373,000 award to Gerhard Wagner at Harvard Medical School for research into large proteins using nuclear magnetic resonance spectroscopy.

The Agilent Thought Leader Award will support Gerhard and his laboratory's research developing fast and efficient assignment methods for large proteins using high magnetic field NMR spectroscopy, and then making them accessible to the structural biology community, Agilent said.

The laboratory is affiliated with the department of biological chemistry and molecular pharmacology at HMS.

"NMR spectroscopy has still a tremendous potential to grow and provide unique information about important biological systems, such as large multidomain proteins, protein complexes, and membrane proteins," Wagner said in a statement. The award, he added, will be used to further innovations with the technology.

"This will provide tools for generating new insights into structures of large macromolecular complexes, understanding of biological mechanisms, and design of new drugs to fight human disease," he said.

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.